Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 220,988,975 papers from all fields of science
Search
Sign In
Create Free Account
PSI 6130
Known as:
PSI-6130
, PSI6130
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
The Discovery of Sofosbuvir: A Liver-Targeted Nucleotide Prodrug for the Treatment and Cure of HCV
M. Sofia
,
P. Furman
Topics in Medicinal Chemistry
2019
Corpus ID: 199043294
Over the last 15 years, an increase in knowledge of the structure, function, life cycle, and pathogenesis of hepatitis C virus…
Expand
2017
2017
The Financialization of a Cure: A Political Economy of Biomedical Innovation, Pricing, and Public Health
V. Roy
2017
Corpus ID: 158620988
The Financialization of a Cure: A Political Economy of Biomedical Innovation, Pricing, and Public Health Victor Roy Sofosbuvir…
Expand
2013
2013
Patent battle lines drawn as sofosbuvir gains approval
C. Harrison
Nature reviews. Drug discovery
2013
Corpus ID: 27028912
hepatitis C virus (HCV) drug was approved by the US Food and Drug Administration on 6 December, the specialist antiviral company…
Expand
2011
2011
Design,synthesis and conversion evaluation in rats of PSI-6130 prodrugs
Nie Ai-hua
2011
Corpus ID: 88083578
Hepatitis C virus(HCV),is one of the major causes of cirrhosis,hepatocellular carcinoma.HCV infection affects 180 million people…
Expand
2010
2010
Alone or in Combination with Pegylated Interferon-a 2 a and Ribavirin Prevents Hepatitis C Virus ( HCV ) Replication and Selection of Resistant Variants in HCV-Infected Patients
S. Pogam
,
A. Seshaadri
,
+8 authors
I. Nájera
2010
Corpus ID: 106405523
Introduction. RG7128 (prodrug of PSI-6130) shows potent antiviral efficacy in patients infected with hepatitis C virus (HCV…
Expand
2009
2009
90 PRECLINICAL STUDIES OF ANA598 COMBINED WITH OTHER ANTI-HCV AGENTS DEMONSTRATE POTENTIAL OF COMBINATION TREATMENT
P. A. Thompson
,
Rupal A Patel
,
K. Steffy
,
J. Appleman
2009
Corpus ID: 72987114
2008
2008
Combinations of 2'-C-Methylcytidine Analogues with Interferon-α2b and Triple Combination with Ribavirin in the Hepatitis C Virus Replicon System
L. Bassit
,
Jason P. Grier
,
M. Bennett
,
R. Schinazi
Antiviral Chemistry & Chemotherapy
2008
Corpus ID: 36965462
Background: Hepatitis C virus (HCV) polymerase is an essential enzyme for HCV replication and has multiple inhibitor binding…
Expand
2008
2008
The mechanism of action of beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent…
E. Murakami
,
C. Niu
,
+7 authors
P. Furman
Antimicrobial Agents and Chemotherapy
2008
Corpus ID: 34322417
beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) is a potent inhibitor of hepatitis C virus (HCV) RNA replication in an…
Expand
2007
2007
Pharmacokinetics of the Antiviral Agent β-d-2′-Deoxy-2′-Fluoro-2′-C-Methylcytidine in Rhesus Monkeys
G. Asif
,
S. Hurwitz
,
Junxing Shi
,
B. Hernández-Santiago
,
R. Schinazi
Antimicrobial Agents and Chemotherapy
2007
Corpus ID: 25965584
ABSTRACT β-d-2′-Deoxy-2′-fluoro-2′-C-methylcytidine (PSI-6130) is an effective inhibitor of hepatitis C virus (HCV) replication…
Expand
2007
2007
[590] INHIBITION OF HCV REPLICATION BY PSI-6130: MECHANISM OF BIOCHEMICAL ACTIVATION AND INHIBITION
P. Furman
,
E. Murakami
,
Haiying Bao
,
J. Symons
,
M. Otto
2007
Corpus ID: 71215162
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE